IP Library Granted Patent US 7,208,589
Granted Patent B2
US 7,208,589 · App. 10/855,541 · Granted Apr 24, 2007

Flea ultraspiracle nucleic acid molecules and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,208,589
App. No.
10/855,541
Granted
Apr 24, 2007
Kind
B2
Abstract

We claim a flea ultraspiracle nucleic acid molecule encoding an ultraspiracle protein, and a composition comprising the isolated nucleic acid molecule. Also, we claim a method of recombinantly producing the ultraspiracle protein thereof.

Claims (10)

1. An isolated nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of (a) a nucleic acid sequence that encodes a protein having an amino acid sequence selected from the group consisting of SEQ ID NO:27, SEQ ID NO:68, and SEQ ID NO:69, wherein said protein has ultraspiracle activity; and (b) a nucleic acid sequence fully complementary to the nucleic acid sequence of (a).

2. The nucleic acid molecule of claim 1 , wherein said nucleic acid molecule comprises a nucleic acid sequence selected from the group consisting of SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:29, and SEQ ID NO:31.

3. The nucleic acid molecule of claim 1 , wherein said nucleic acid molecule encodes a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NO:27, SEQ ID NO:68, and SEQ ID NO:69.

4. A recombinant molecule comprising a nucleic acid molecule as set forth in claim 1 (a) operatively linked to a transcription control sequence.

5. A recombinant cell comprising a nucleic acid molecule as set forth in claim 1 (a).

6. A composition comprising an excipient and an isolated nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of (a) a nucleic acid sequence that encodes a protein having an amino acid sequence selected from the group consisting of SEQ ID NO:27 SEQ ID NO:68, and SEQ ID NO:69, wherein said protein has ultraspiracle activity; and (b) a nucleic acid sequence fully complementary to the nucleic acid sequence of (a).

7. The composition of claim 6 , wherein said nucleic acid molecule comprises a nucleic acid sequence selected from the group consisting of SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:29, and SEQ ID NO:31.

8. The composition of claim 6 , wherein said nucleic acid molecule encodes a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NO:27, SEQ ID NO:68, and SEQ ID NO:69.

9. A method to produce a protein, said method comprising (a) culturing a cell transformed with an isolated nucleic acid molecule comprising a nucleic acid sequence that encodes a protein having an amino acid sequence selected from the group consisting of SEQ ID NO:27, SEQ ID NO:68, and SEQ ID NO:69, wherein said protein has ultraspiracle activity; and (b) recovering the expressed protein.

10. A composition comprising an isolated nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of (a) a nucleic acid sequence that encodes a protein having an amino acid sequence selected from the group consisting of SEQ ID NO:27, SEQ ID NO:68, SEQ ID NO:69, wherein said protein has ultraspiracle activity; and (b) a nucleic acid sequence fully complementary to a nucleic acid sequence of (a).

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Dec 14, 2023
From: JPMORGAN CHASE BANK, N.A.
To: HESKA CORPORATION; DIAMOND ANIMAL HEALTH, INC.; HESKA IMAGING, LLC
Reel/Frame 066012/0887 →
SECURITY INTEREST Recorded Oct 24, 2017
From: HESKA CORPORATION; DIAMOND ANIMAL HEALTH, INC.; HESKA IMAGING, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 044636/0972 →
SECURITY AGREEMENT Recorded Feb 26, 2009
From: HESKA CORPORATION
To: WELLS FARGO BUSINESS CREDIT, INC.
Reel/Frame 022354/0170 →